Metastasis Patterns and Prognosis of Octogenarians with NSCLC: A Population-based Study

被引:27
作者
Gu, Yu [1 ,2 ]
Zhang, Junhua [1 ,2 ]
Zhou, Zhirui [1 ,2 ]
Liu, Di [1 ,2 ]
Zhu, Hongcheng [1 ,2 ]
Wen, Junmiao [1 ,2 ]
Xu, Xinyan [1 ,2 ]
Chen, Tianxiang [3 ]
Fan, Min [1 ,2 ]
机构
[1] Fudan Univ, Dept Radiat Oncol, Shanghai Canc Ctr, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai 200030, Peoples R China
来源
AGING AND DISEASE | 2020年 / 11卷 / 01期
基金
中国国家自然科学基金;
关键词
NSCLC; octogenarian; age-related; metastasis; prognosis; cancer; lung; CELL-LUNG-CANCER; EGFR MUTATION STATUS; BRAIN METASTASES; AGE; IMPACT; IMMUNOSENESCENCE; COMORBIDITY; MANAGEMENT; SURVIVAL; THERAPY;
D O I
10.14336/AD.2019.0414
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Non-small cell lung cancer (NSCLC) is the most common cancer and the leading cause of cancerrelated deaths worldly. ide. Age at diagnosis of advanced NSCLC is much older, but studies describing the practice patterns for octogenarians with distant metastasis NSCLC are limited. A retrospective, population-based study using national representative data from the Surveillance, Epidemiology, and End Results (SEER) program was conducted to evaluate 34 882 NSCLC patients with extrathoracic metastases from 2010 to 2013. Patients were classified into three groups (older group: >= 80 yrs, middle-aged group: 60-79 yrs, and younger group: <= 59 yrs). The role of different age at diagnosis of NSCLC in metastasis patterns was investigated, and survival of different age groups of metastatic NSCLC was assessed. The analysis revealed that older patients were more likely to only have bone or liver metastasis (p< 0.001), but less likely to have brain only metastasis (p<0.001) and multiple metastatic sites (p< 0.001) than other two groups. Age at diagnosis was an independent risk factor for different metastasis types. Older group had the worst overall survival (p<0.001) and cancer-specific survival (p<0.001). Furthermore, older age patients with only bone metastasis had the best cancer specific survival (p<0.05) while younger patients with only brain metastasis had the best prognosis (p<0.001). Over 60% octogenarians with metastatic NSCLC did not receive anti-cancer therapy and had the highest rate of cancer deaths among all patients. Our results may help clinicians make positive decisions regarding personalized treatment of metastatic NSCLC in the elderly.
引用
收藏
页码:82 / 92
页数:11
相关论文
共 31 条
  • [1] [Anonymous], CHRONOBIOL INT
  • [2] [Anonymous], POP PROJ US AG SEX R
  • [3] The Effects of Aging on the Molecular and Cellular Composition of the Prostate Microenvironment
    Bianchi-Frias, Daniella
    Vakar-Lopez, Funda
    Coleman, Ilsa M.
    Plymate, Stephen R.
    Reed, May J.
    Nelson, Peter S.
    [J]. PLOS ONE, 2010, 5 (09): : 1 - 16
  • [4] Results and impact of routine assessment of comorbidity in elderly patients with non-small-cell lung cancer aged &gt; 80 years
    Breen, David
    Barlesi, Fabrice
    Zemerli, Myriam
    Doddoli, Christophe
    Torre, Jean-Philippe
    Thomas, Pascal
    Astoul, Philippe
    [J]. CLINICAL LUNG CANCER, 2007, 8 (05) : 331 - 334
  • [5] Health Care Disparities Among Octogenarians and Nonagenarians With Stage III Lung Cancer
    Cassidy, Richard J.
    Zhang, Xinyan
    Switchenko, Jeffrey M.
    Patel, Pretesh R.
    Shelton, Joseph W.
    Tian, Sibo
    Nanda, Ronica H.
    Steuer, Conor E.
    Pillai, Rathi N.
    Owonikoko, Taofeek K.
    Ramalingam, Suresh S.
    Fernandez, Felix G.
    Force, Seth D.
    Gillespie, Theresa W.
    Curran, Walter J.
    Higgins, Kristin A.
    [J]. CANCER, 2018, 124 (04) : 775 - 784
  • [6] A large, single-center, real-world study of clinicopathological characteristics and treatment in advanced ALK-positive non-small-cell lung cancer
    Chen, Gang
    Chen, Xi
    Zhang, Yaxiong
    Yan, Fang
    Fang, Wenfeng
    Yang, Yunpeng
    Hong, Shaodong
    Miao, Siyu
    Wu, Manli
    Huang, Xiaodan
    Luo, Youli
    Zhou, Cong
    Gong, Run
    Huang, Yan
    Zhou, Ningning
    Zhao, Hongyun
    Zhang, Li
    [J]. CANCER MEDICINE, 2017, 6 (05): : 953 - 961
  • [7] Confavreux Cyrille B, 2014, Bonekey Rep, V3, P580, DOI 10.1038/bonekey.2014.75
  • [8] The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non-Small Cell Lung Cancer
    David, Elizabeth A.
    Clark, James M.
    Cooke, David T.
    Melnikow, Joy
    Kelly, Karen
    Canter, Robert J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : 1636 - 1645
  • [9] Population-Based Estimates of Survival Benefit Associated with Combined Modality Therapy in Elderly Patients with Locally Advanced Non-small Cell Lung Cancer
    Davidoff, Amy J.
    Gardner, James F.
    Seal, Brian
    Edelman, Martin J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (05) : 934 - 941
  • [10] Older cancer patients in cancer clinical trials are underrepresented. Systematic literature review of almost 5000 meta- and pooled analyses of phase III randomized trials of survival from breast, prostate and lung cancer
    Dunn, Cita
    Wilson, Andrew
    Sitas, Freddy
    [J]. CANCER EPIDEMIOLOGY, 2017, 51 : 113 - 117